https://www.selleckchem.com/pr....oducts/etomoxir-na-s
The binding of GLM and IFX appears to be affected by TNFA and TNFA , respectively. TNFA and TNFA may be associated with autoimmune diseases, whereas TNFA , TNFA , and TNFA may be pathogenic per se. These variants may contribute to the observed inter-individual variability in response to anti-TNFA mAbs treatments and be used as markers to predict responses, and thus optimize therapeutic benefits to the patients. These variants may contribute to the observed inter-individual variability in response to anti-TNFA mAbs treatments an
Like
Comment
Share
